Axogen, Inc. — Director's Dealing 2025

Jun 20, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2025-06-19

Reporting Person: TYNDALL JOSEPH A. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-19	Restricted Stock Units	$	A	14150	Acquired		Common Stock (14150)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.